Agilent Technologies has announced the opening of a new life sciences instrument manufacturing facility in Singapore. The facility will produce the company's LC-MS instruments for the global market.
Agilent Technologies has announced the opening of a new life sciences instrument manufacturing facility in Singapore. The facility will produce the company's liquid chromatography–mass spectrometry (LC–MS) instruments for the global market.
"The opening of the LC–MS manufacturing facility marks a milestone in Agilent's continued investment in Singapore, which began in 1970," said Bill Sullivan, company president and CEO. "Singapore is the ideal location for this facility as it will provide us with greater access to the life sciences instrument market in Asia. The new facility also will bring us closer to our customers, as the pharmaceutical and biopharmaceutical industries have become an important part of Singapore's overall economy and investment strategy."
The facility is located within the Agilent Life Sciences Group Order Fulfillment Centre, located in Yishun, Singapore. The centre will be responsible for management of the supply-chain network — including planning, procurement, value-added engineering and logistics.
"I am pleased that Singapore will be an integral part of Agilent's global manufacturing network," said Mr S Iswaran, senior minister of state for trade & industry and education. "Life sciences companies can further tap Singapore as a base in Asia to drive business expansion and innovation for the region."
The facility will produce the company’s 6100 series Single-Quadrupole LC–MS, 6200 series Accurate-Mass Time-of-Flight LC–MS, 6400 series Triple Quadrupole LC–MS, and the 6500 series Accurate-Mass Quadrupole Time-of-Flight LC–MS.
"The new Agilent LC–MS manufacturing facility will attract top talent and enable the development of skilled engineers and chemists in Singapore as these are sophisticated high-end scientific instruments," said Soon-Chai Gooi, president of Agilent Technologies, Singapore and Malaysia.
According to the company these instruments are widely used by pharmaceutical companies, from basic research through manufacturing and quality control; and also serve customers in biotechnology, bioagriculture, food safety, chemical, petrochemical, forensics, homeland security, environmental, academic and government markets.
More information is available at www.chem.agilent.com
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
Exploring The Chemical Subspace of RPLC: A Data-driven Approach
November 11th 2024Saer Samanipour from the Van ‘t Hoff Institute for Molecular Sciences (HIMS) at the University of Amsterdam spoke to LCGC International about the benefits of a data-driven reversed-phase liquid chromatography (RPLC) approach his team developed.